Literature DB >> 29173299

Chronic Pulmonary Insufficiency of Prematurity: Developing Optimal Endpoints for Drug Development.

Robin Steinhorn1, Jonathan M Davis2, Wolfgang Göpel3, Alan Jobe4, Steven Abman5, Matthew Laughon6, Eduardo Bancalari7, Judy Aschner8, Roberta Ballard9, Anne Greenough10, Linda Storari11, Merran Thomson12, Ronald L Ariagno13, Laura Fabbri11, Mark A Turner14.   

Abstract

Entities:  

Keywords:  bronchopulmonary dysplasia; chronic lung disease; long term outcomes; respiratory failure

Mesh：

Year:  2017        PMID： 29173299     DOI： 10.1016/j.jpeds.2017.08.006

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  30 in total

Review 1.  The Challenge of Risk Stratification of Infants Born Preterm in the Setting of Competing and Disparate Healthcare Outcomes.

Authors:  Halana V Whitehead; Christopher C McPherson; Zachary A Vesoulis; Barbara A Cohlan; Rakesh Rao; Barbara B Warner; F Sessions Cole
Journal:  J Pediatr       Date:  2020-08       Impact factor: 4.406

2.  Developmental Origins of Chronic Lung Diseases. Mechanical Stretch, Micro-RNAs, and Hydrogels.

Authors:  Matthew D McGraw; Laura G Sherlock; Kolene L Bailey; Steven H Abman
Journal:  Am J Respir Cell Mol Biol       Date:  2018-08       Impact factor: 6.914

3.  Urine gastrin-releasing peptide in the first week correlates with bronchopulmonary dysplasia and post-prematurity respiratory disease.

Authors:  Judith A Voynow; Kimberley Fisher; Mary E Sunday; Charles M Cotten; Aaron Hamvas; Karen D Hendricks-Muñoz; Brenda B Poindexter; Gloria S Pryhuber; Clement L Ren; Rita M Ryan; Jack K Sharp; Sarah P Young; Haoyue Zhang; Rachel G Greenberg; Amy H Herring; Stephanie D Davis
Journal:  Pediatr Pulmonol       Date:  2020-01-29

Review 4.  Bronchopulmonary dysplasia.

Authors:  Bernard Thébaud; Kara N Goss; Matthew Laughon; Jeffrey A Whitsett; Steven H Abman; Robin H Steinhorn; Judy L Aschner; Peter G Davis; Sharon A McGrath-Morrow; Roger F Soll; Alan H Jobe
Journal:  Nat Rev Dis Primers       Date:  2019-11-14       Impact factor: 52.329

5.  Differences in clinical and laboratory biomarkers for short and long-term respiratory outcomes in preterm neonates.

Authors:  Richard B Parad; Janis L Breeze; Norma Terrin; Lynette K Rogers; Carolyn M Salafia; Anne Greenough; Jonathan M Davis
Journal:  Pediatr Pulmonol       Date:  2021-08-26

6.  Reply.

Authors:  Rosemary D Higgins; Alan H Jobe
Journal:  J Pediatr       Date:  2018-12-24       Impact factor: 4.406

7.  Early Pulmonary Vascular Disease in Preterm Infants Is Associated with Late Respiratory Outcomes in Childhood.

Authors:  Peter M Mourani; Erica W Mandell; Maxene Meier; Adel Younoszai; John T Brinton; Brandie D Wagner; Sanne Arjaans; Brenda B Poindexter; Steven H Abman
Journal:  Am J Respir Crit Care Med       Date:  2019-04-15       Impact factor: 21.405

Review 8.  Recent advances in antenatal factors predisposing to bronchopulmonary dysplasia.

Authors:  Elizabeth Taglauer; Steven H Abman; Roberta L Keller
Journal:  Semin Perinatol       Date:  2018-10-05       Impact factor: 3.300

9.  Pulmonary hypertension in extremely preterm infants: a call to standardize echocardiographic screening and follow-up policy.

Authors:  Sanne Arjaans; Elvira A H Zwart; Marc Roofthooft; Elisabeth M W Kooi; Arend F Bos; Rolf M F Berger
Journal:  Eur J Pediatr       Date:  2021-02-02       Impact factor: 3.183

10.  Newer bronchopulmonary dysplasia definitions and prediction of health economics impacts in very preterm infants.

Authors:  Chie Kurihara; Lishi Zhang; Michel Mikhael
Journal:  Pediatr Pulmonol       Date:  2020-11-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.